SCHEMBL484474

SCHEMBL484474

N#Cc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccc4c(c2)C(NC(=O)c2ccccc2Cl)CC4)CC3)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 6/20 0.47
CYP3A4 P08684 6/20 0.47
USP2 O75604 5/20 0.47
CHRM2 P08172 3/20 0.46
CHRM3 P20309 3/20 0.46
MAPK1 P28482 2/20 0.44
CCR8 P51685 2/20 0.43
KCNH2 Q12809 2/20 0.43
ACKR3 P25106 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
TSHR P16473 5/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.42
ALDH1A1 P00352 2/20 0.42
GLA P06280 1/20 0.42
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
TAS1R2 Q8TE23 1/20 0.42
FAAH O00519 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484584 0.96 CYP3A4 (0.43) CYP2D6CYP3A4USP2CHRM2CHRM3
SCHEMBL484809 0.94 USP2 (0.53) CYP2D6CYP3A4USP2MAPK1SMN1; SMN2
SCHEMBL484736 0.90 USP2 (0.49) CYP2D6CYP3A4USP2CHRM2CHRM3
SCHEMBL484722 0.90 CYP3A4 (0.51) CYP2D6CYP3A4USP2CHRM2CHRM3
SCHEMBL2818242 0.90 CYP3A4 (0.49) CYP2D6CYP3A4USP2CHRM2CHRM3
SCHEMBL484732 0.89 CYP3A4 (0.48) CYP2D6CYP3A4USP2MAPK1SMN1; SMN2
SCHEMBL484596 0.88 ALDH1A1 (0.45) CYP2D6CYP3A4USP2MAPK1SMN1; SMN2
SCHEMBL485059 0.87 TAS1R3 (0.43) CYP2D6CYP3A4USP2CHRM2CHRM3
SCHEMBL484340 0.87 CYP3A4 (0.52) CYP2D6CYP3A4USP2CHRM2CHRM3
SCHEMBL484792 0.86 CYP3A4 (0.55) CYP2D6CYP3A4USP2MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP3A4 3781/4885USP2 4864/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP3A4 3781/4885USP2 4864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.